Stock Fundamentals

Company Information

Company Name
Abcellera Biologics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA00288U1066
CIK: 0001703057
CUSIP: 00288U106
Currency: USD
Full Time Employees: 562
Phone: 604 559 9005
Fiscal Year End: December
IPO Date: Dec 11, 2020
Description:

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Address:

150 W 4th Avenue, Vancouver, BC, Canada, V5Y 1G6

Directors & Officers

Name Title Year Born
Dr. Carl L.G. Hansen Ph.D. CEO, President & Chairperson 1975
Mr. Andrew Booth M.B.A. Chief Financial Officer 1974
Dr. Veronique Lecault Ph.D. CTO & Director 1985
Mr. Tryn T. Stimart Esq., J.D., M.Sc. Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer 1970
Mr. Andrew Knowles M.Sc. Vice President of Operations NA
Marcie Thiessen CPA, CGA Senior Director of Finance & Accounting NA
Mr. Martin Hogan M.Sc. Senior Director of Strategic Finance & IR NA
Ms. Tiffany Chiu B.Sc., Ph.D. Vice President of Communications NA
Caitlin Webster CIPD, M.Sc. Director of Talent Development NA
Mr. Murray McCutcheon Ph.D. Senior Vice President of Partnering NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 26, 2023 Andrew Booth N/A Purchase 14.50K $6.85 $99.33K
May 26, 2023 Holdings Ltd. Thermopylae N/A Purchase 153.00K $6.52 $997.56K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 30.28M Mar 31, 2026 9.91% $0.61 9.99%
Capital World Investors 13.36M Mar 31, 2026 4.38% $0.01 0.00%
Two Sigma Investments LLC 10.56M Mar 31, 2026 3.46% $0.03 81.76%
TD Waterhouse Canada Inc 9.56M Mar 31, 2026 3.13% $0.10 42,576.51%
UBS Asset Mgmt Americas Inc 7.58M Mar 31, 2026 2.48% $0.01 -3.82%
Two Sigma Advisers, LLC 4.88M Dec 31, 2025 1.60% $0.03 1.63%
UBS Group AG 4.21M Mar 31, 2026 1.38% $0.00 117.03%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 4.11M Mar 31, 2026 1.34% $0.38 0.00%
BlackRock Inc 4.04M Mar 31, 2026 1.32% $0.00 4.51%
Driehaus Capital Management LLC 4.02M Mar 31, 2026 1.32% $0.10 6.70%
The Goldman Sachs Group Inc 3.75M Mar 31, 2026 1.23% $0.00 -13.66%
Bank of America Corp 3.00M Mar 31, 2026 0.98% $0.00 13.94%
Jefferies Financial Group Inc 2.75M Mar 31, 2026 0.90% $0.07 0.00%
Alyeska Investment Group, L.P. 2.59M Mar 31, 2026 0.85% $0.03 0.00%
Tudor Investment Corp Et AL 2.27M Mar 31, 2026 0.74% $0.01 26.59%
Morgan Stanley - Brokerage Accounts 2.22M Mar 31, 2026 0.73% $0.00 -25.88%
Guardian Partners Inc. 1.79M Mar 31, 2026 0.59% $0.52 0.00%
Renaissance Technologies Corp 1.51M Mar 31, 2026 0.49% $0.01 -36.77%
Citadel Advisors Llc 1.36M Mar 31, 2026 0.45% $0.00 -25.81%
Millennium Management LLC 1.29M Mar 31, 2026 0.42% $0.00 -27.01%

Shares Statistics

Shares Outstanding: 305.38M
Shares Float: 205.32M
% Insiders: 2,280.00%
% Institutions: 4,319.00%
Short % Float: 20.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 American Funds SMALLCAP World A 13.36M 4.38% ▲ 0.00% Mar 31, 2026
2 UBS Lux Dgtl Hlth Eq Fd seeding P acc 2.70M 0.89% ▼ 2.94% Feb 28, 2026
3 ACATIS Datini Valueflex Fonds A 1.86M 0.61% ▲ 0.00% Apr 30, 2026
4 iShares Biotechnology ETF 1.71M 0.56% ▲ 1.95% May 29, 2026
5 Heptagon Driehaus US Micro Cap Eq C$ Acc 632.82K 0.21% ▲ 1.98% Apr 30, 2026
6 State Street® SPDR® Ptf Dev Wld exUS ETF 564.32K 0.18% ▲ 0.00% May 29, 2026
7 iShares Genomics Immnlgy & Hlthcr ETF 412.63K 0.14% ▲ 0.00% May 29, 2026
8 BlackRock Advantage Small Cap Core Instl 339.62K 0.11% ▼ 0.26% Apr 30, 2026
9 iShares Healthcare Innov ETF USD Acc 296.82K 0.10% ▲ 0.00% May 29, 2026
10 Driehaus Micro Cap Growth USD 249.24K 0.08% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $1.24B
Trailing P/E: 0.00
Forward P/E: 27.55

Financial Highlights

Market Cap: $1.60B
EBITDA: $-188.28M
Book Value: $3.09
Earnings/Share: $-0.48
Profit Margin: -181.74%
Operating Margin: -691.75%
ROA (TTM): -9.99%
ROE (TTM): -14.68%
Revenue (TTM): $79.21M
Revenue/Share (TTM): $0.26
Earnings Growth (YOY): 45.90%
Revenue Growth (YOY): 96.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 11.32x 0.01x 0.29x N/A -0.04x
2024-12-31 9.81x 0.00x 0.22x N/A -0.02x
2023-12-31 7.33x 0.01x 0.23x N/A -0.03x
2022-12-31 8.67x 0.00x 0.20x 53.53x 0.02x
2021-12-31 7.70x 0.00x 0.22x -19.68x -23.62x
2020-12-31 7.86x 0.00x 0.17x 23.96x 0.02x
2019-12-31 1.60x 0.41x 0.56x -19.70x -27.41x
2018-12-31 2.36x 0.30x 0.46x -3.55x 2.39x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ABCL.US!